Proliferative human cell sources applied as biocomponent in bioartificial livers: a review

Bibliography

• Bernal W, Auzinger G, Dhawan A, Acute liver failure. Lancet 2010;376:190-201
   PubMed Web of Science ®Google Scholar
• Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis 2008;28:201-9
   PubMed Web of Science ®Google Scholar
• Van de Kerkhove MP, Hoekstra R, Chamuleau RA, Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216-30
   PubMed Web of Science ®Google Scholar
• Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology 2001;34:447-55
   PubMed Web of Science ®Google Scholar
• Sgroi A, Serre-Beinier V, Morel P, What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 2009;87:457-66
   PubMed Web of Science ®Google Scholar
• Carpentier B, Gautier A, Legallais C. Artificial and bioartificial liver devices: present and future. Gut 2009;58:1690-702
   Google Scholar
• Butterworth RF. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int 2003;23(Suppl 3):5-9
   PubMedGoogle Scholar
• Moroni F, Carpenedo R, Venturini I, Oxindole in pathogenesis of hepatic encephalopathy. Lancet 1998;351:1861
   PubMed Web of Science ®Google Scholar
• Bjerring PN, Hauerberg J, Jorgensen L, Brain hypoxanthine concentration correlates to lactate/pyruvate ratio but not intracranial pressure in patients with acute liver failure. J Hepatol 2010;53:1054-8
   PubMed Web of Science ®Google Scholar
• Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol 2008;590:417-22
   PubMed Web of Science ®Google Scholar
• Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest 1986;16:193-7
   PubMed Web of Science ®Google Scholar
• Melchior GW, Castle CK, Murray RW, Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels. J Biol Chem 1994;269:8044-51
   PubMed Web of Science ®Google Scholar
• Lisman T, Caldwell SH, Burroughs AK, Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010;53:362-71
   PubMed Web of Science ®Google Scholar
• Wong F. Drug insight: the role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007;54:43-51
   Google Scholar
• Wu Z, Han M, Chen T, Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int 2010;30:782-94
   PubMed Web of Science ®Google Scholar
• Sauer IM, Zeilinger K, Obermayer N, Primary human liver cells as source for modular extracorporeal liver support – a preliminary report. Int J Artif Organs 2002;25:1001-5
   PubMed Web of Science ®Google Scholar
• Baccarani U, Sanna A, Cariani A, Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl 2003;9:506-12
   PubMed Web of Science ®Google Scholar
• Flendrig LM, Chamuleau RA, Maas MA, Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability. J Hepatol 1999;30:311-20
   PubMed Web of Science ®Google Scholar
• Flendrig LM, Calise F, Di Florio E, Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999;22:701-9
   PubMed Web of Science ®Google Scholar
• Tsiaoussis J, Newsome PN, Nelson LJ, Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl 2001;7:2-10
   PubMed Web of Science ®Google Scholar
• Chamuleau RA, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis 2005;20:327-35
   PubMed Web of Science ®Google Scholar
• Aden DP, Fogel A, Plotkin S, Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-16
   PubMed Web of Science ®Google Scholar
• Nyberg SL, Remmel RP, Mann HJ, Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 1994;220:59-67
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Shimada M, Tsujita E, Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant 2001;10:717-22
   PubMed Web of Science ®Google Scholar
• Hongo T, Kajikawa M, Ishida S, Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver. J Biosci Bioeng 2005;99:237-44
   PubMed Web of Science ®Google Scholar
• Nibourg GA, Huisman MT, van der Hoeven TV, Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Liver Transpl 2010;16:1075-85
   PubMed Web of Science ®Google Scholar
• Coward SM, Legallais C, David B, Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs 2009;33:1117-26
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33
   PubMed Web of Science ®Google Scholar
• Fukuda J, Okamura K, Nakazawa K, Efficacy of a polyurethane foam/spheroid artificial liver by using human hepatoblastoma cell line (Hep G2). Cell Transplant 2003;12:51-8
   PubMed Web of Science ®Google Scholar
• Rahman TM, Selden C, Khalil M, Alginate-encapsulated human hepatoblastoma cells in an extracorporeal perfusion system improve some systemic parameters of liver failure in a xenogeneic model. Artif Organs 2004;28:476-82
   PubMed Web of Science ®Google Scholar
• Kelly JH, Koussayer T, He D, Assessment of an extracorporeal liver assist device in anhepatic dogs. Artif Organs 1992;16:418-22
   PubMed Web of Science ®Google Scholar
• Carraro A, Hsu WM, Kulig KM, In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices 2008;10:795-805
   Google Scholar
• David B, Dufresne M, Nagel MD, In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol Prog 2004;20:1204-12
   PubMed Web of Science ®Google Scholar
• Hoekstra R, Deurholt T, ten Bloemendaal L, Assessment of in vitro applicability of reversibly immortalized NKNT-3 cells and clonal derivatives. Cell Transplant 2006;15:423-33
   PubMed Web of Science ®Google Scholar
• Chen G, Palmer AF. Hemoglobin regulates the metabolic, synthetic, detoxification, and biotransformation functions of hepatoma cells cultured in a hollow fiber bioreactor. Tissue Eng Part A 2010;16:3231-40
   PubMed Web of Science ®Google Scholar
• Gautier A, Carpentier B, Dufresne M, Impact of alginate type and bead diameter on mass transfers and the metabolic activities of encapsulated C3A cells in bioartificial liver applications. Eur Cell Mater 2011;21:94-106
   PubMed Web of Science ®Google Scholar
• Mavri-Damelin D, Damelin LH, Eaton S, Cells for bioartificial liver devices: the human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia. Biotechnol Bioeng 2007;99:644-651
   Web of Science ®Google Scholar
• Kinasiewicz A, Smietanka A, Gajkowska B, Impact of oxygenation of bioartificial liver using perfluorocarbon emulsion perftoran on metabolism of human hepatoma C3A cells. Artif Cells Blood Substit Immobil Biotechnol 2008;36:525-34
   PubMed Web of Science ®Google Scholar
• Kinasiewicz A, Gautier A, Lewinska D, Culture of C3A cells in alginate beads for fluidized bed bioartificial liver. Transplant Proc 2007;39:2911-13
   PubMed Web of Science ®Google Scholar
• Kinasiewicz A, Gautier A, Lewiska D, Three-dimensional growth of human hepatoma C3A cells within alginate beads for fluidized bioartificial liver. Int J Artif Organs 2008;31:340-7
   PubMed Web of Science ®Google Scholar
• Kinasiewicz A, Smietanka A, Dudzinski K, Spongy polyethersulfone membrane for hepatocyte cultivation: studies on human hepatoma C3A cells. Artif Organs 2008;32:747-52
   PubMed Web of Science ®Google Scholar
• Kelly JH, Koussayer T, He DE, An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 1992;15:329-35
   PubMed Web of Science ®Google Scholar
• Sussman NL, Chong MG, Koussayer T, Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992;16:60-5
   PubMed Web of Science ®Google Scholar
• Ellis AJ, Hughes RD, Wendon JA, Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-51
   PubMed Web of Science ®Google Scholar
• Millis JM, Cronin DC, Johnson R, Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation 2002;74:1735-46
   PubMed Web of Science ®Google Scholar
• Kosuge M, Takizawa H, Maehashi H, A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor. Liver Int 2007;27:101-8
   PubMed Web of Science ®Google Scholar
• Kanai H, Marushima H, Kimura N, Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy. Artif Organs 2007;31:148-51
   PubMed Web of Science ®Google Scholar
• Kawada M, Nagamori S, Aizaki H, Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines. In Vitro Cell Dev Biol Anim 1998;34:109-15
   PubMed Web of Science ®Google Scholar
• Gripon P, Rumin S, Urban S, Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002;99:15655-60
   PubMed Web of Science ®Google Scholar
• Guillouzo A, Corlu A, Aninat C, The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 2006;168:66-73
   PubMed Web of Science ®Google Scholar
• Darnell M, Schreiter T, Zeilinger K, Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor. Drug Metab Dispos 2011;39:1131-8
   PubMed Web of Science ®Google Scholar
• Flendrig LM, la Soe JW, Jorning GG, In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997;26:1379-92
   PubMed Web of Science ®Google Scholar
• Murray AW. Recycling the cell cycle: cyclins revisited. Cell 2004;116:221-34
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005;14:867-74
   Google Scholar
• Werner A, Duvar S, Muthing J, Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system. Ann NY Acad Sci 1999;875:364-8
   PubMed Web of Science ®Google Scholar
• Werner A, Duvar S, Muthing J, Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers. Biotechnol Bioeng 2000;68:59-70
   PubMed Web of Science ®Google Scholar
• Deurholt T, van Til NP, Chhatta AA, Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol 2009;9:89
   PubMedGoogle Scholar
• Poyck PP, van Wijk AC, van der Hoeven TV, Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol 2008;48:266-75
   PubMed Web of Science ®Google Scholar
• Akiyama I, Tomiyama K, Sakaguchi M, Expression of CYP3A4 by an immortalized human hepatocyte line in a three-dimensional culture using a radial-flow bioreactor. Int J Mol Med 2004;14:663-8
   PubMed Web of Science ®Google Scholar
• Fukaya K, Asahi S, Nagamori S, Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT. In Vitro Cell Dev Biol Anim 2001;37:266-9
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Okitsu T, Nakaji S, Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs 2003;6:236-44
   PubMedGoogle Scholar
• Kobayashi N. Life support of artificial liver: development of a bioartificial liver to treat liver failure. J Hepatobiliary Pancreat Surg 2009;16:113-17
   PubMedGoogle Scholar
• Deurholt T, ten Bloemendaal L, Chhatta AA, In vitro functionality of human fetal liver cells and clonal derivatives under proliferative conditions. Cell Transplant 2006;15:811-22
   PubMed Web of Science ®Google Scholar
• Poyck PP, Hoekstra R, van Wijk AC, Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. Liver Transpl 2007;13:589-98
   PubMed Web of Science ®Google Scholar
• Ring A, Gerlach J, Peters G, Hepatic maturation of human fetal hepatocytes in four-compartment three-dimensional perfusion culture. Tissue Eng Part C Methods 2010;16:835-45
   PubMed Web of Science ®Google Scholar
• Schmelzer E, Triolo F, Turner ME, Three-dimensional perfusion bioreactor culture supports differentiation of human fetal liver cells. Tissue Eng Part A 2010;16:2007-16
   PubMed Web of Science ®Google Scholar
• Mitaka T, Kojima T, Mizuguchi T, Growth and maturation of small hepatocytes isolated from adult rat liver. Biochem Biophys Res Commun 1995;214:310-17
   PubMed Web of Science ®Google Scholar
• Pavlic M, Libiseller K, Hermann M, Small human hepatocytes in rotary culture for treatment of alcohol addicts? A pilot study. Alcohol Clin Exp Res 2007;31:729-36
   PubMed Web of Science ®Google Scholar
• Wurm M, Lubei V, Caronna M, Introduction of a novel prototype bioartificial liver support system utilizing small human hepatocytes in rotary culture. Tissue Eng Part A 2009;15:1063-73
   PubMed Web of Science ®Google Scholar
• Wurm M, Woess C, Libiseller K, Challenging small human hepatocytes with opiates: further characterization of a novel prototype bioartificial liver. Tissue Eng Part A 2010;16:807-13
   PubMed Web of Science ®Google Scholar
• Fonsato V, Herrera MB, Buttiglieri S, Use of a rotary bioartificial liver in the differentiation of human liver stem cells. Tissue Eng Part C Methods 2009;16:123-32
   Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22
   PubMed Web of Science ®Google Scholar
• Parekkadan B, van Poll D, Suganuma K, Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007;2:e941
   PubMed Web of Science ®Google Scholar
• Kazemnejad S, Allameh A, Soleimani M, Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J Gastroenterol Hepatol 2009;24:278-87
   PubMed Web of Science ®Google Scholar
• Miki T, Ring A, Gerlach J. Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions. Tissue Eng Part C Methods 2011;17:557-68
   PubMed Web of Science ®Google Scholar
• Enosawa S, Miyashita T, Suzuki S, Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver. Cell Transplant 2000;9:711-15
   PubMed Web of Science ®Google Scholar
• Enosawa S, Miyashita T, Saito T, The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model. Cell Transplant 2006;15:873-80
   PubMed Web of Science ®Google Scholar
• Enosawa S, Miyashita T, Fujita Y, In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure. Cell Transplant 2001;10:429-33
   PubMed Web of Science ®Google Scholar
• Enosawa S, Miyashita T, Tanaka H, Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2. Transplant Proc 2001;33:1945-7
   PubMed Web of Science ®Google Scholar
• Wang N, Tsuruoka S, Yamamoto H, The bioreactor with CYPA4- and glutamine synthetase-introduced HepG2 cells: treatment of hepatic failure dog with diazepam overdose. Artif Organs 2005;29:681-4
   PubMed Web of Science ®Google Scholar
• Okitsu T, Kobayashi N, Jun HS, Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 2004;53:105-12
   PubMed Web of Science ®Google Scholar
• Shinoda M, Tilles AW, Kobayashi N, A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res 2007;137:130-40
   PubMed Web of Science ®Google Scholar
• Inoue Y, Miyazaki M, Tsuji T, Reactivation of liver-specific gene expression in an immortalized human hepatocyte cell line by introduction of the human HNF4alpha2 gene. Int J Mol Med 2001;8:481-7
   PubMed Web of Science ®Google Scholar
• Bhatia SN, Balis UJ, Yarmush ML, Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999;13:1883-900
   PubMed Web of Science ®Google Scholar
• Saito M, Matsuura T, Masaki T, Reconstruction of liver organoid using a bioreactor. World J Gastroenterol 2006;12:1881-8
   PubMed Web of Science ®Google Scholar
• Endo M, Enosawa S, Ozaki M, Artificial mimicking of physiological active transport by a membrane co-cultured with two different cells: hepatic origin HepG2 and renal origin PCTL-MDR. Artif Organs 2002;26:806-11
   PubMed Web of Science ®Google Scholar
• Tsuruoka S, Sugimoto KI, Ueda K, Removal of digoxin and doxorubicin by multidrug resistance protein-overexpressed cell culture in hollow fiber. Kidney Int 1999;56:154-63
   PubMed Web of Science ®Google Scholar
• Takahashi M, Sakurai M, Enosawa S, Double-compartment cell culture apparatus: construction and biochemical evaluation for bioartificial liver support. Cell Transplant 2006;15:945-52
   PubMed Web of Science ®Google Scholar
• Hoekstra R, Nibourg GAA, Van der Hoeven TV, The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 2011;43:1483-9
   PubMed Web of Science ®Google Scholar
• Yagi H, Parekkadan B, Suganuma K, Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15:3377-88
   Google Scholar
• Carraro A, Flaibani M, Cillo U, A combining method to enhance the in vitro differentiation of hepatic precursor cells. Tissue Eng Part C Methods 2011;16:1543-51
   Web of Science ®Google Scholar
• Brieva TA, Moghe PV. Functional engineering of hepatocytes via heterocellular presentation of a homoadhesive molecule, E-cadherin. Biotechnol Bioeng 2001;76:295-302
   PubMed Web of Science ®Google Scholar
• Hussain SZ, Sneddon T, Tan X, Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res 2004;292:157-69
   PubMed Web of Science ®Google Scholar
• Snykers S, De Kock J, Rogiers V, In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 2009;27:577-605
   PubMed Web of Science ®Google Scholar
• Mancone C, Conti B, Amicone L, Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytes. J Hepatol 2010;52:234-43
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Fujiwara T, Westerman KA, Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000;287:1258-62
   PubMed Web of Science ®Google Scholar
• Ryall J, Rachubinski RA, Nguyen M, Regulation and expression of carbamyl phosphate synthetase I mRNA in developing rat liver and Morris hepatoma 5123D. J Biol Chem 1984;259:9172-6
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Noguchi H, Totsugawa T, Insertion of a suicide gene into an immortalized human hepatocyte cell line. Cell Transplant 2001;10:373-6
   PubMed Web of Science ®Google Scholar
• Shimada M, Yamashita Y, Tanaka S, Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liver. Hepatogastroenterology 2007;54:814-820
   PubMed Web of Science ®Google Scholar
• Sussman NL, Gislason GT, Conlin CA, The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994;18:390-396
   PubMed Web of Science ®Google Scholar
• Harm S, Stroble K, Hartmann J, Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device – the hybrid-MDS. Int J Artif Organs 2009;32:769-778
   PubMed Web of Science ®Google Scholar
• Iwahori T, Matsuno N, Johjima Y, Radial flow bioreactor for the creation of bioartificial liver and kidney. Transplant Proc 2005;37:212-214
   PubMed Web of Science ®Google Scholar
• Iwahori T, Matsuura T, Maehashi H, CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 2003;37:665-673
   PubMed Web of Science ®Google Scholar
• Sun BS, Pan J, Clayton MM, Hepatitis C virus replication in stably transfected HepG2 cells promotes hepatocellular growth and tumorigenesis. J Cell Physiol. 2004;201:447-58
   PubMed Web of Science ®Google Scholar
• Lu DD, Chen YC, Zhang XR, The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma. Yale J Biol Med. 2003;76:55-62
   PubMedGoogle Scholar